Oculir
About:
Oculir develops non-invasive glucose meter that measures glucose from the conjunctiva of the eye.
Website: http://www.oculir.com
Top Investors: Canaan Partners, Three Arch Partners, ONSET Ventures, Shepherd Ventures, CHL Medical Partners
Description:
Oculir develops non-invasive glucose meter that measures glucose from the conjunctiva of the eye.
Total Funding Amount:
$7.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2003-01-01
Founders:
John Burd
Number of Employees:
1-10
Last Funding Date:
2005-12-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai